Editorial
No access
Published Online: 1 March 2017

Returning Results in Biobank Research: Global Trends and Solutions

Publication: Genetic Testing and Molecular Biomarkers
Volume 21, Issue Number 3

Abstract

In many countries around the world, biobanks have become crucial resources for the conduct of biomedical research, facilitating many kinds of research, including international collaborations. The focus of this special issue is on a looming ethical issue that has become a focus of debate—the return of research results and incidental findings to biobank participants. Although the articles in this issue do not provide a final answer to the ethical, legal, and social dilemmas that arise in the context of the return of results, the intent of the collection is to approach this issue from multiple perspectives and within an international context spanning the United Kingdom, continental Europe including Eastern Europe, the United States, and the Middle East.

Get full access to this article

View all available purchase options and get full access to this article.

References

ACMG Board of Directors (2015) ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med 17:68–69.
ACMG Board of Directors (2016). Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med [Epub ahead of print].
Beier K, Schnorrer S (2011) Ethical and legal aspects of human tissue and biobank research in Europe: Report on the Tiss.EU project and its results. Scripted. J Law Technol Soc 8:99–105.
Bledsoe MJ, Clayton EW, McGuire AL, et al. (2013) Return of research results from genomic biobanks: Cost matters. Genet Med 15:157–159.
Elger BS (2010) Ethical Issues of Human Genetic Databases: A Challenge to Classical Health Research Ethics. Routledge, New York.
Elger BS, Biller-Andorno N, Capron AM (eds) (2008) Ethical Issues in Governing Biobanks: Global Perspectives. Routledge, New York.
Garrett SB, Koenig BA, Brown A, et al. (2015) EngageUC: developing an efficient and ethical approach to biobanking research at the University of California. Clin Transl Sci 8:362–366.
Gottweis H, Kaye J (2012) Biobanks for Europe: A Challenge for Governance. European Commission, Directorate-General for Research and Innovation; Luxembourg: Publications Office of the European Union.
Green RC, et al. (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565–574.
Kinkorová J (2016) Biobanks in the era of personalized medicine: Objectives, challenges, and innovation. EPMA J 7:4.
Locock L, Boylan AR (2016) Biosamples as gifts? How participants in biobanking projects talk about donation. Health Expect 19:805–816.
Moore LJ, Casper MJ (2014) The Body: Social and Cultural Dissections. Routledge, London, New York.
Stranger M, Kaye J (2009) Principles and Practices in Biobank Governance. Routledge, New York.
Wolf SM, Crock BN, Van Ness B, et al. (2012) Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 14:361–384.
Wolf SM (2013) Return of results in genomic biobank research: Ethics matters. Genet Med 15:157–159.

Information & Authors

Information

Published In

cover image Genetic Testing and Molecular Biomarkers
Genetic Testing and Molecular Biomarkers
Volume 21Issue Number 3March 2017
Pages: 128 - 131
PubMed: 28146646

History

Published in print: March 2017
Published online: 1 March 2017
Published ahead of print: 1 February 2017

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Eva De Clercq
Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
Jane Kaye
Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Susan M. Wolf
Law School, Medical School, University of Minnesota, Minneapolis, Minnesota.
Barbara A. Koenig
Institute for Health Aging, University of California, San Francisco, California.
Bernice S. Elger
Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
University Center of Legal Medicine of Geneva and Lausanne, University of Geneva, Geneva, Switzerland.

Notes

Address correspondence to:Eva De Clercq, PhDInstitute for Biomedical EthicsUniversity of BaselBernoullistrasse 28Basel CH-4056Switzerland
E-mail: [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Copy the content Link

Share on social media

Back to Top